相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Stability studies for the identification of critical process parameters for a pharmaceutical production of the Orf virus
Friederike Eilts et al.
VACCINE (2023)
Assessing detergent-mediated virus inactivation, protein stability, and impurity clearance in biologics downstream processes
Hasin Feroz et al.
BIOTECHNOLOGY AND BIOENGINEERING (2022)
Orf Virus-Based Vectors Preferentially Target Professional Antigen-Presenting Cells, Activate the STING Pathway and Induce Strong Antigen-Specific T Cell Responses
Melanie Mueller et al.
FRONTIERS IN IMMUNOLOGY (2022)
Comparison of sample preparation techniques for the physicochemical characterization of Orf virus particles
Friederike Eilts et al.
JOURNAL OF VIROLOGICAL METHODS (2022)
A Summary of Practical Considerations for the Application of the Steric Exclusion Chromatography for the Purification of the Orf Viral Vector
Friederike Eilts et al.
MEMBRANES (2022)
Membrane-based steric exclusion chromatography for the purification of a recombinant baculovirus and its application for cell therapy
Keven Lothert et al.
JOURNAL OF VIROLOGICAL METHODS (2020)
Orf Virus-Based Therapeutic Vaccine for Treatment of Papillomavirus-Induced Tumors
M. Schneider et al.
JOURNAL OF VIROLOGY (2020)
Orf Virus-Based Vaccine Vector D1701-V Induces Strong CD8+ T Cell Response against the Transgene but Not against ORFV-Derived Epitopes
Alena Reguzova et al.
VACCINES (2020)
Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector
Keven Lothert et al.
JOURNAL OF BIOTECHNOLOGY (2020)
A scalable downstream process for the purification of the cell culture-derived Orf virus for human or veterinary applications
Keven Lothert et al.
JOURNAL OF BIOTECHNOLOGY (2020)
Genomic Characterization of Orf Virus Strain D1701-V (Parapoxvirus) and Development of Novel Sites for Multiple Transgene Expression
Hanns-Joachim Rziha et al.
VIRUSES-BASEL (2019)
Inactivated Orf-virus shows disease modifying antiviral activity in a guinea pig model of genital herpesvirus infection
Astrid Friebe et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2018)
Stability and suitability for storage and distribution of Ad26.ZEBOV/MVA-BN®-Filo heterologous prime-boost Ebola vaccine
Martinus A. H. Capelle et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Physical Characterization and Stabilization of a Lentiviral Vector Against Adsorption and Freeze-Thaw
Ozan S. Kumru et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Viral vaccine stabilizers: status and trends
F. M. C. Cardoso et al.
ACTA VIROLOGICA (2017)
Charge state of arginine as an additive on heat-induced protein aggregation.
Takumi Miyatake et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Arginine as a protein stabilizer and destabilizer in liquid formulations
Nam Ah Kim et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Live attenuated and inactivated viral vaccine formulation and nasal delivery: Potential and challenges
Jose L. Tlaxca et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Effect of Stabilization and Reconstitution on the Stability of a Novel Strain of Live Attenuated Orf Vaccine (ORFV MUK59/05)
Veerakyathappa Bhanupraka et al.
(2015)
M-M-R®II manufactured using recombinant human albumin (rHA) and M-M-R®II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children
Richard T. Wiedmann et al.
VACCINE (2015)
Molecular Genetic Analysis of Orf Virus: A Poxvirus That Has Adapted to Skin
Stephen B. Fleming et al.
VIRUSES-BASEL (2015)
Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies
Ozan S. Kumru et al.
BIOLOGICALS (2014)
Enhancing poxvirus vectors vaccine immunogenicity
Juan Garcia-Arriaza et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline
Katrine Jensen et al.
Pharmaceutics (2014)
A New Rabies Vaccine Based on a Recombinant Orf Virus (Parapoxvirus) Expressing the Rabies Virus Glycoprotein
Ralf Amann et al.
JOURNAL OF VIROLOGY (2013)
New Orf Virus (Parapoxvirus) Recombinant Expressing H5 Hemagglutinin Protects Mice against H5N1 and H1N1 Influenza A Virus
Joerg Rohde et al.
PLOS ONE (2013)
ORFV: A Novel Oncolytic and Immune Stimulating Parapoxvirus Therapeutic
Julia L. Rintoul et al.
MOLECULAR THERAPY (2012)
Interactions of formulation excipients with proteins in solution and in the dried state
Satoshi Ohtake et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV)
Joerg Rohde et al.
VACCINE (2011)
L-Proline reduces IgG dimer content and enhances the stability of intravenous immunoglobulin (IVIG) solutions
Reinhard Bolli et al.
BIOLOGICALS (2010)
Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs
E. M. A. van Rooij et al.
VACCINE (2010)
Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara
Guus F. Rimmelzwaan et al.
EXPERT REVIEW OF VACCINES (2009)
Opportunities and challenges of developing thermostable vaccines
Dexiang Chen et al.
EXPERT REVIEW OF VACCINES (2009)
ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine
Richard N. Greenberg et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Pitfalls in diagnosing human poxvirus infections
Andreas Nitsche et al.
JOURNAL OF CLINICAL VIROLOGY (2007)
Suppression of protein interactions by arginine: A proposed mechanism of the arginine effects
Tsutomu Arakawa et al.
BIOPHYSICAL CHEMISTRY (2007)
Stability of diluted smallpox vaccine under simulated clinical conditions
RL Kline et al.
VACCINE (2005)
Phase I comparability of recombinant human albumin and human serum albumin
D Bosse et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Appearance of the bona fide spiral tubule of Orf virus is dependent on an intact 10-kilodalton viral protein
D Spehner et al.
JOURNAL OF VIROLOGY (2004)
Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice
T Fischer et al.
JOURNAL OF VIROLOGY (2003)